It Finally Happened. DEA Moves Medical Marijuana To Schedule III
After fifty years of federal lies about the plant, Washington admits medical marijuana has medical value, but recreational cannabis stays trapped in Schedule I for now.

Half a century of prohibitionist dogma cracked open on April 23, 2026. The Department of Justice and the Drug Enforcement Administration issued a final order moving certain marijuana products out of Schedule I, the category reserved for drugs with supposedly no medical value, and into Schedule III.
The order follows President Trump's December 2025 executive action directing the government to get rescheduling done. It covers two categories: drug products containing marijuana approved by the FDA, and marijuana subject to qualifying medical only licenses issued by states. In plain English, if you are a state licensed medical marijuana operator, the federal government no longer classifies your product alongside heroin.
That is a big deal, and not just symbolically. Schedule I and II businesses are barred from deducting ordinary business expenses under Section 280E of the tax code, a punitive rule that has bled legal cannabis companies dry while the illicit market pays no taxes at all. State licensed medical operators now gain deduction eligibility, and the Acting Attorney General has encouraged Treasury to consider retrospective relief from past 280E liability for medical operators. Recreational operators get nothing yet.
Because make no mistake, this order is narrow. State licensed recreational marijuana stays in Schedule I. So do synthetic cannabinoids and unlicensed operations. The tens of millions of Americans who buy legal adult use cannabis in their own states are still, in the eyes of federal law, trafficking in a substance the government pretends is more dangerous than fentanyl analogs sitting in Schedule II.
There are strings attached for medical operators too. They must register with the DEA and comply with Schedule III recordkeeping and security requirements. State medical licensees who apply within 60 days of the Federal Register notice can keep operating under their state licenses while the DEA reviews their applications, and the agency has committed to processing those early applications within six months.
The bigger fight is already scheduled. The DEA set a new hearing beginning June 29, 2026 to evaluate broader changes to marijuana's federal status, including whether the entire plant belongs in Schedule III. HHS and FDA scientists already concluded years ago that marijuana meets the Schedule III criteria. The science was never the obstacle. The politics were.
Give credit where due. After the Biden era rescheduling effort collapsed into administrative limbo, this administration actually signed the order. Now finish the job. A plant that is legal medicine in nearly forty states and legal for adults in twenty four should not sit in Schedule I anywhere, for anyone. The June hearing is the next test of whether Washington follows the science or the special interests.
Sources
- https://www.foley.com/insights/publications/2026/04/dea-issues-long-awaited-final-order-rescheduling-certain-marijuana-products-to-schedule-iii-what-it-means-what-it-doesnt-and-what-comes-next/
- https://www.federalregister.gov/documents/2026/04/28/2026-08177/schedules-of-controlled-substances-rescheduling-of-marijuana
- https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana
- https://www.saul.com/insights/alert/dea-reschedules-fda-approved-marijuana-products-and-state-licensed-medical-marijuana
Questions readers ask
What is Media Mogul News?
Media Mogul News is an independent, reader-supported news site led by Chief Editor Nate Jurewicz. We cover the stories corporate media skips: political corruption, Big Pharma, the deep state, election integrity, cannabis freedom, crypto and the money behind all of it.
What is your political stance?
We are pro-liberty, pro-cannabis, anti-war and anti-corruption, and we hold both parties to the same standard. We are not a party outlet. When the people we agree with get something wrong, we say so.
How is Media Mogul funded?
By readers. We take no pharmaceutical advertising and no money from the industries we cover. Support comes from newsletter readers, donations and Media Mogul merchandise.
